A qualitative study of increasing β-blocker use after myocardial infarction -: Why do some hospitals succeed?

被引:226
|
作者
Bradley, EH
Holmboe, ES
Mattera, JA
Roumanis, SA
Radford, MJ
Krumholz, HM
机构
[1] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
[3] Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA
来源
关键词
D O I
10.1001/jama.285.20.2604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Based on evidence that beta -blockers can reduce mortality in patients with acute myocardial infarction (AMI), many hospitals have initiated performance improvement efforts to increase prescription of beta -blockers at discharge, Determination of the factors associated with such improvements may provide guidance to hospitals that have been less successful in increasing beta -blocker use, Objectives To identify factors that may influence the success of improvement efforts to increase beta -blocker use after AMI and to develop a taxonomy for classifying such efforts. Design, Setting, and Participants Qualitative study in which data were gathered from in-depth interviews conducted in March-June 2000 with 45 key physician, nursing, quality management, and administrative participants at 8 US hospitals chosen to represent a range of hospital sizes, geographic regions, and changes in beta -blocker use rates between October 1996 and September 1999. Main Outcome Measures initiatives, strategies, and approaches to improve care for patients with AMI. Results The interviews revealed 6 broad factors that characterized hospital-based improvement efforts: goals of the efforts, administrative support, support among clinicians, design and implementation of improvement initiatives, use of data, and modifying variables. Hospitals with greater improvements in beta -blocker use over time demonstrated 4 characteristics not found in hospitals with less or no improvement: shared goals for improvement, substantial administrative support, strong physician leadership advocating beta -blocker use, and use of credible data feedback, Conclusions This study provides a context for understanding efforts to improve care in the hospital setting by describing a taxonomy for classifying and evaluating such efforts. In addition, the study suggests possible elements of successful efforts to increase beta -blocker use for patients with AMI.
引用
收藏
页码:2604 / 2611
页数:8
相关论文
共 50 条
  • [21] Hospital-level performance improvement - Beta-blocker use after acute myocardial infarction
    Bradley, EH
    Herrin, J
    Mattera, JA
    Holmboe, ES
    Wang, YF
    Frederick, P
    Roumanis, SA
    Radford, MJ
    Krumhoz, HM
    MEDICAL CARE, 2004, 42 (06) : 591 - 599
  • [22] "It is up to me with a little support" - adherence after myocardial infarction: a qualitative study
    Levy, D.
    Admi, H.
    Eilon-Moshe, Y.
    Eisen, I.
    Nikolsky, E.
    Gepstein, L.
    Satran, C.
    Ore, L.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2020, 19 (1_SUPPL) : S21 - S21
  • [23] What Distinguishes Top-Performing Hospitals in Acute Myocardial Infarction Mortality Rates? A Qualitative Study
    Curry, Leslie A.
    Spatz, Erica
    Cherlin, Emily
    Thompson, Jennifer W.
    Berg, David
    Ting, Henry H.
    Decker, Carole
    Krumholz, Harlan M.
    Bradley, Elizabeth H.
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (06) : 384 - +
  • [24] What role do pharmacists play in mediating antibiotic use in hospitals? A qualitative study
    Broom, Alex
    Broom, Jennifer
    Kirby, Emma
    Plage, Stefanie
    Adams, Jon
    BMJ OPEN, 2015, 5 (11):
  • [25] Beta-blocker use and up-titration after acute ST-segment elevation myocardial infarction: a cohort study
    Christel, Bruggmann
    Stephane, Fournier
    Alice, Panchaud
    Olivier, Muller
    Farshid, Sadeghipour
    Pierre, Voirol
    SWISS MEDICAL WEEKLY, 2020, 150
  • [26] The association between calcium-channel blocker and/or beta blocker use and mortality in elderly diabetic patients after myocardial infarction: The CCP experience
    Vivekananthan, D
    Wheeler, S
    Frederick, PD
    CIRCULATION, 2000, 102 (18) : 408 - 408
  • [27] BETA-BLOCKER USE IN THE TREATMENT OF COMMUNITY-HOSPITAL PATIENTS DISCHARGED AFTER MYOCARDIAL-INFARCTION
    SIAL, SH
    MALONE, M
    FREEMAN, JL
    BATTIOLA, R
    NACHODSKY, J
    GOODWIN, JS
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1994, 9 (11) : 599 - 605
  • [28] Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it "Ok" to Discontinue?
    Kezerashvili, Anna
    Marzo, Kevin
    De Leon, Joshua
    CURRENT CARDIOLOGY REVIEWS, 2012, 8 (01) : 77 - 84
  • [29] Association of β-blocker use at discharge and prognosis of oldest old with acute myocardial infarction: a prospective cohort study
    Hui-Hui Liu
    Sha Li
    Yan Zhang
    Meng Zhang
    Hui-Wen Zhang
    Jie Qian
    Ke-Fei Dou
    Jian-Jun Li
    European Geriatric Medicine, 2024, 15 : 169 - 178
  • [30] Association of β-blocker use at discharge and prognosis of oldest old with acute myocardial infarction: a prospective cohort study
    Liu, Hui-Hui
    Li, Sha
    Zhang, Yan
    Zhang, Meng
    Zhang, Hui-Wen
    Qian, Jie
    Dou, Ke-Fei
    Li, Jian-Jun
    EUROPEAN GERIATRIC MEDICINE, 2024, 15 (01) : 169 - 178